The Indian pharmaceutical market grew 12.1% year-on-year in July 2026. Sun Pharma emerged as a leading contributor to this expansion. The sector rebound follows two years of relatively weak performance.
Price increases accounted for 6% of the growth. New product launches contributed 3.7%. Patient volume recovery added 2.3%.
Brokerage firm Nomura reported that nearly every drugmaker outperformed the market average.